RESUMO
BACKGROUND: The production of reactive oxygen species (ROS) by fibroblasts has been suggested to contribute to scleroderma pathogenesis. Infrared-mediated hyperthermia has recently been shown to be of benefit in scleroderma. AIM: As the contribution of neutrophils and monocytes to ROS formation in scleroderma is unknown, we studied respiratory burst in these cell types. We also aimed to test the hypothesis that near-infrared (IRA) treatment may effect burst activity. METHODS: We determined respiratory burst in patients with scleroderma (n = 22) and age- and sex-matched controls (n = 20) at baseline, and after high-level stimulation by phorbolmyristyl acetate (PMA) and low-level stimulation by non-opsonized zymosan. Respiratory burst was also assessed before and after a series of infrared-mediated hyperthermia treatments. RESULTS: Unexpectedly, we observed no increase but instead a slight but statistically significant reduction in baseline and zymosan-stimulated respiratory burst in scleroderma neutrophils (P < 0.001) and monocytes (P < 0.005). This decrease in burst activity was nonspecific, as it was also observed in patients with another active inflammatory disease, psoriasis. IRA treatment induced a cell-type-specific normalization of respiratory burst only in neutrophils, but not in monocytes. Intriguingly, neutrophil-specific normalization of ROS formation persisted for 6 weeks after the end of IRA treatment, in concordance with the previously reported clinical responses to this therapy. CONCLUSION: Neutrophils and monocytes do not exhibit cell-autonomous overproduction of ROS in scleroderma, thereby implicating fibroblasts as main source for clinically relevant ROS accumulation. Furthermore, repeated mild infrared-mediated hyperthermia exerts a lasting cell-type-specific effect on neutrophils.
Assuntos
Hipertermia Induzida/métodos , Raios Infravermelhos/uso terapêutico , Neutrófilos/metabolismo , Explosão Respiratória , Escleroderma Sistêmico/sangue , Adulto , Idoso , Estudos de Casos e Controles , Relação Dose-Resposta a Droga , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Monócitos/efeitos dos fármacos , Monócitos/metabolismo , Neutrófilos/efeitos dos fármacos , Espécies Reativas de Oxigênio/sangue , Explosão Respiratória/efeitos dos fármacos , Escleroderma Sistêmico/terapia , Índice de Gravidade de Doença , Acetato de Tetradecanoilforbol/farmacologia , Técnicas de Cultura de Tecidos , Zimosan/farmacologiaRESUMO
BACKGROUND: Evaluation of treatments for Raynaud's phenomenon (RP) requires objective response parameters in addition to clinical activity scores. Thermographic monitoring of fingertip re-warming after cold challenge has been widely used but usually requires sophisticated equipment. We have previously shown that fingertip re-warming after cold challenge follows a first-order transient response curve that can be described by a single variable, designated tau. OBJECTIVES: Here, we describe a novel device termed a duosensor, which records the tau value upon cold challenge in an automated manner. METHODS: We determined tau values in healthy probands, patients with primary or secondary RP associated with autoimmune disease and patients with scleroderma-associated RP following cold challenge, to determine assay variability, sensitivity and specificity. RESULTS: Duosensor-based thermography exhibited low intraindividual variability in healthy probands. As expected, tau values in RP patients were significantly increased compared with controls (8.08 +/- 3.65 min vs. 3.23 +/- 1.65 min). The duosensor-determined tau value yielded a specificity of 94.6% and predictive value of 95.3% for the presence of RP in a retrospective analysis of 139 patients. Furthermore, in a cohort of scleroderma patients with RP, patient self-assessment of RP severity correlated with tau values. CONCLUSIONS: Taken together, the present data suggest that tau value determination provides a suitable outcome measure for clinical studies of novel RP treatments. As the duosensor is a simple stand-alone device requiring no supporting equipment and minimal personnel attention, it should allow RP activity monitoring even in clinical settings with minimal technical infrastructure.
Assuntos
Temperatura Baixa , Dedos/fisiopatologia , Doença de Raynaud/diagnóstico , Temperatura Corporal/fisiologia , Estudos de Coortes , Humanos , Raios Infravermelhos , Pletismografia/instrumentação , Pletismografia/métodos , Valor Preditivo dos Testes , Doença de Raynaud/fisiopatologia , Fluxo Sanguíneo Regional/fisiologia , Estudos Retrospectivos , Escleroderma Sistêmico/diagnóstico , Escleroderma Sistêmico/fisiopatologia , Sensibilidade e Especificidade , Índice de Gravidade de Doença , Termografia/métodosRESUMO
The role of protein synthesis was tested for memory formation after color learning in honey bees. Free flying bees were trained to a feeding place. Before the color conditioning started, foragers accustomed to flying to the feeding place received an injection of either cycloheximide in bee ringer or bee ringer alone into the brain. Afterward, the animals were trained appetitively to a specific colored target by three training trials. During the test situation, two targets with different colors and no reward were presented. The choice behavior toward the two targets was evaluated. The first test immediately followed the last trial, the second test 24 h later. A comparison between cycloheximide- and ringer-injected bees showed no significant difference in choice behavior in either test. Although the injection of cycloheximide causes the inhibition of protein synthesis (> 95%) for a period of 3 h, the memory for the learned color signal is not affected. These results corroborate those found for the olfactory conditioning of the proboscis extension reflex in bees (Wittstock, Kaatz, & Menzel, 1993, Menzel, Gaio, Gerberding, Nemrava, & Wittstock, 1993).
Assuntos
Comportamento Apetitivo/efeitos dos fármacos , Abelhas/efeitos dos fármacos , Percepção de Cores/efeitos dos fármacos , Cicloeximida/farmacologia , Rememoração Mental/efeitos dos fármacos , Proteínas do Tecido Nervoso/biossíntese , Animais , Aprendizagem por Associação/efeitos dos fármacos , Encéfalo/efeitos dos fármacos , Feminino , Reflexo/efeitos dos fármacos , Olfato/efeitos dos fármacosRESUMO
The honeybee forms a long-term memory in different training situations that lasts for a lifetime, but the cellular mechanisms of long-term memory formation are not known. We analyzed the dependency of long-term memory on the de novo brain protein synthesis. The protein synthesis inhibitor cycloheximide was injected via the median ocellus directly into the brain. 3H-leucine incorporation into brain proteins was inhibited by > 95% for > 3 hr. The time of protein synthesis inhibition was prolonged by a second injection of the same dose. Worker honeybees were conditioned to an olfactory stimulus at different times before and after injection. The proboscis extension response (PER) of bees restrained in tubes was classically conditioned with sugar water applied first to the antennae followed by feeding (unconditioned stimulus) paired with odor presentation (conditioned stimulus). The bees were tested by presenting the odor alone at different times up to 24 hr after injection. No significant reduction in the probability of the conditioned response in cycloheximide-treated bees was found when compared to the Ringer-injected controls in 4 series of experiments. Since protein synthesis was inhibited between 7 hr pre- and 7 hr postconditioning without affecting the formation of long-term memory, a possible role of de novo protein synthesis in the formation of long-term memory after olfactory conditioning of the PER is not supported by these experiments.